BioVentures Board

The BioVentures Board comprises a select group of individuals from the realms of business, education, philanthropy and the investment community. The Board advises BioVentures on policies and practices to facility basic, medical, clinical and translational research, the development of the information, products and processes resulting from such research, and the investment and management of assets to meet priority needs of UAMS and BioVentures.

Steve Abell
Vice President of Strategic Innovations and Investments
Arkansas Blue Cross and Blue Shield
and Executive Vice President of USAble Corporation

Remi Barbier, MBA
President & CEO
Cassava Sciences

Louise Epstein, MBA
Director of University Partnerships
Walton Personal Philanthropy Group

Amanda George, MHSA, CPA
UAMS Ex Officio Member
Vice Chancellor for Finance and Chief Financial Officer
University of Arkansas for Medical Sciences

Nancy Gray, PhD
UAMS Ex Officio Member
President, BioVentures, LLC
Professor, Pharmacology and Toxicology
University of Arkansas for Medical Sciences

Kevin Heyeck
Venture Partner
6 Dimensions Capital

Shuk-Mei Ho, PhD
UAMS Ex Officio Member
Vice Chancellor for Research
University of Arkansas for Medical Sciences

Bobby Sandage, PhD
General Partner
Cultivation Capital Life Sciences